Related Experiment Video
Updated: May 27, 2025

Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
Bell's Palsy: Description, Diagnosis, and Current Management.
Seth Gardner1, Lexi Garber1, John Grossi1
1Department of Anatomy, Lake Erie College of Osteopathic Medicine, Bradenton, USA.
Bell's palsy, or idiopathic facial paralysis, affects the seventh cranial nerve causing unilateral facial weakness. Most patients recover fully within six months, irrespective of treatment, which includes corticosteroids, antivirals, and physical therapy.
Area of Science:
- Neurology
- Ophthalmology
Background:
- Bell's palsy is a common idiopathic neuropathy affecting the seventh cranial nerve (facial nerve).
- It typically presents as sudden-onset unilateral facial weakness, impacting forehead wrinkling, nasolabial folds, mouth corner, and causing drooling.
- Associated comorbidities may include diabetes, obesity, and pregnancy.
Purpose of the Study:
- To provide a comprehensive overview of Bell's palsy, including its clinical presentation, potential comorbidities, diagnostic approach, and treatment options.
- To emphasize the generally favorable prognosis of Bell's palsy.
Main Methods:
- Diagnosis of exclusion based on clinical presentation of unilateral facial weakness.
- Review of current treatment modalities, including pharmacological (corticosteroids, antivirals) and non-pharmacological (acupuncture, physical therapy, chiropractic) interventions.
Main Results:
- The clinical presentation of Bell's palsy is distinct and recognizable by clinicians.
- Treatment options are varied, encompassing corticosteroids, antivirals, or combination therapy, alongside physical therapy and alternative treatments.
- The majority of patients experience complete recovery within a six-month timeframe.
Conclusions:
- Bell's palsy is characterized by unilateral facial nerve dysfunction with a generally good prognosis.
- While various treatments exist, spontaneous recovery is common within six months.
- Understanding comorbidities and diagnostic criteria is crucial for effective management.
Related Concept Videos
Tonsillitis II: Management
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Prosopagnosia
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Acute Pancreatitis II: Clinical Manifestations and Management

